BetterLife Pharma Inc. (CSE:BETR)

Market Cap	10.21M -51.6%
Revenue (ttm)	n/a
Net Income	-1.50M
EPS	-0.01
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	126,000
Open	0.0600
Previous Close	0.0600
Day's Range	0.0600 - 0.0600
52-Week Range	0.0400 - 0.1000
Beta	0.54
Analysts	n/a
Price Target	n/a
Earnings Date	Jun 5, 2026

About BetterLife Pharma

BetterLife Pharma Inc., a biotechnology company, primarily focuses on developing compounds for the treatment of mental disorders in Canada. It is also involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight viral infections. The company’s products pipeline includes BETR-001 for the treatment of major depressive disorder, anxiety disorder, and neuropathic pain and other neuro-psychiatric and neurological disorders; and BETR-002 to t...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2002
• Employees: 7
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: BETR